Edition:
United Kingdom

Profile: Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,916.00GBp
4:35pm BST
Change (% chg)

8.00 (+0.28%)
Prev Close
2,908.00
Open
2,912.00
Day's High
2,926.00
Day's Low
2,888.00
Volume
390,405
Avg. Vol
187,526
52-wk High
3,080.00
52-wk Low
1,992.00

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Dechra Veterinary Products International and Dechra Pharmaceuticals Manufacturing. It manufactures and markets Companion Animal, Equine, Food producing Animal Products and Nutrition. The NA Pharmaceuticals Segment consists of Dechra Veterinary Products US, Putney, Dechra Veterinary Products Canada, and Dechra-Brovel that sell Companion Animal, Equine and Food Producing Animal Products into those territories. The Pharmaceuticals Research and Development Segment includes its pharmaceutical research and development activities. Its offerings include Osphos, Zycortal and Vetoryl.

Company Address

Dechra Pharmaceuticals PLC

24 Cheshire Business Park
Cheshire Avenue
NORTHWICH     CW9 7UA
P: +441606.814730
F: +441606.814731

Company Web Links